The ARHINASD (Allergic Rhinitis in Pediatric Subjects With Nasal Septum Deviation) Project
NCT ID: NCT06139185
Last Updated: 2025-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
69 participants
OBSERVATIONAL
2023-01-01
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Different Disease Control Indices in Children With Asthma and Rhinitis
NCT00952835
Short and Mid-term Repeatability of Active Anterior Rhinomanometry (AAR) Measurements in Paediatric Age
NCT03286049
Mediators in Nasal Hyperreactivity in Allergic Rhinitis and Chronic Rhinosinusitis
NCT04286542
Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases
NCT00815984
Nasal Budesonide Efficacy on Nasal FeNO in Children With Allergic Rhinitis
NCT02409563
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with nasal septum deviation
Data collection
Data collection
Patients without nasal septum deviation
Data collection
Data collection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection
Data collection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* both sexes
* age between 6 and 14 years
* written informed consent.
Exclusion Criteria
* Age \<6 and \>14 years
Concomitant presence of:
* chronic diseases
* malignancies
* immunodeficiency
* chronic infections
* autoimmune diseases
* chronic inflammatory intestinal diseases
* celiac disease
* genetic diseases
* metabolic diseases
* cystic fibrosis
* chronic pulmonary diseases
* malformations of the cardiovascular system
* malformations of the respiratory system
* malformations of the gastrointestinal system
* neuropsychiatric disorders
* neurological diseases
* obesity
* eosinophilic diseases
* antibiotics use in the last 7 days
* cortisone use in the last 7 days
* antihistamines use in the last 7 days
* trauma at nose level in the 3 years before the enrollment,
* history of previous nose surgery, or previous major surgery procedures of gastrointestinal, cardiovascular, urinary or respiratory tract
6 Years
14 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federico II University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roberto Berni Canani, MD, PhD
Medical Doctor, PhD, Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Traslational Medical Science - University of Naples Federico II
Naples, , Italy
University of Naples Federico II
Naples, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
31/23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.